» Articles » PMID: 36386165

Natural Drugs Targeting Inflammation Pathways Can Be Used to Treat Atherosclerosis

Overview
Journal Front Pharmacol
Date 2022 Nov 17
PMID 36386165
Authors
Affiliations
Soon will be listed here.
Abstract

Atherosclerosis (AS) is the chronic gradual degradation of arteries in combination with inflammation. Currently, the main research focus has been on interactions between inflammatory cells, inflammatory mediators, and immune mechanisms, while some studies have reported natural drugs were exerting a critical role against AS, whereas the usage of natural drugs was always limited by various factors such as poor penetration across biological barriers, low bioavailability, and unclear mechanisms. Herein, we reviewed the potential targets for inflammation against AS, discussed the underlying mechanisms of natural drugs for AS, particularly highlighted the dilemma of current research, and finally, offered perspectives in this field.

Citing Articles

A novel degradable PEG superparamagnetic iron oxide capsule coupled with a polyphenolic nano-enzymatic conjugate (PSPM-NE), to treat ROS-driven cardiovascular-diseases, tested in atherosclerosis as a model disease, and hypothesizing autoimmunity as....

Pereira G Front Cardiovasc Med. 2024; 11:1125571.

PMID: 39145281 PMC: 11323396. DOI: 10.3389/fcvm.2024.1125571.


Advances in Atherosclerosis Theranostics Harnessing Iron Oxide-Based Nanoparticles.

Wang S, He H, Mao Y, Zhang Y, Gu N Adv Sci (Weinh). 2024; 11(17):e2308298.

PMID: 38368274 PMC: 11077671. DOI: 10.1002/advs.202308298.


A novel dammarane triterpenoid alleviates atherosclerosis by activating the LXRα pathway.

Huang Y, Ran X, Liu H, Luo M, Qin Y, Yan J Chin Med. 2023; 18(1):72.

PMID: 37322486 PMC: 10273626. DOI: 10.1186/s13020-023-00758-0.

References
1.
Yang X, Liu F, Feng N, Ding X, Chen Y, Zhu S . Berberine Attenuates Cholesterol Accumulation in Macrophage Foam Cells by Suppressing AP-1 Activity and Activation of the Nrf2/HO-1 Pathway. J Cardiovasc Pharmacol. 2020; 75(1):45-53. DOI: 10.1097/FJC.0000000000000769. View

2.
Biasutto L, Zoratti M . Prodrugs of quercetin and resveratrol: a strategy under development. Curr Drug Metab. 2013; 15(1):77-95. DOI: 10.2174/1389200214666131211160005. View

3.
Lu C, Yang Y, Li C, Liu K, Lii C, Chen H . Andrographolide inhibits TNFα-induced ICAM-1 expression via suppression of NADPH oxidase activation and induction of HO-1 and GCLM expression through the PI3K/Akt/Nrf2 and PI3K/Akt/AP-1 pathways in human endothelial cells. Biochem Pharmacol. 2014; 91(1):40-50. DOI: 10.1016/j.bcp.2014.06.024. View

4.
Okawara M, Hashimoto F, Todo H, Sugibayashi K, Tokudome Y . Effect of liquid crystals with cyclodextrin on the bioavailability of a poorly water-soluble compound, diosgenin, after its oral administration to rats. Int J Pharm. 2014; 472(1-2):257-61. DOI: 10.1016/j.ijpharm.2014.06.032. View

5.
Chen S, Lin Y, Huang B, Wang D, Cheng J . Salvianolic acid B suppresses IFN-γ-induced JAK/STAT1 activation in endothelial cells. Thromb Res. 2011; 128(6):560-4. DOI: 10.1016/j.thromres.2011.08.032. View